Unul din obiectivele principale ale Life4me+ - să prevină apariția unor noi cazuri de infecție cu HIV, boli cu transmitere sexuală (TBS), hepatită C și tuberculoză

Aplicația permite stabilirea unei comunicări anonime între medici și persoane care au HIV. Îți permite să organizezi mai ușor programul de administrare a tratamentului și să setezi notificări personalizate și discrete

Toate știrile / August 2018

Arhivă

✕

31 august 2018

7444

FDA approved two new drugs for HIV treatment

FDA approved two new drugs for HIV treatment

The US Food and Drug Administration (FDA) has approved two new drugs for HIV treatment. This happened two months earlier than originally planned. The drugs are suitable for the treatment of adults with the most common strains of the virus and patients who have not received ...

30 august 2018

14817

Pharmacies in Finland began to sell rapid tests for HIV

Pharmacies in Finland began to sell rapid tests for HIV

In Finland, kits for testing HIV for blood drop, which can be used at home, were on sale. To get the result you need only wait 15 minutes.

28 august 2018

7436

EMA will consider the application for registration of the drug for the treatment of HIV infection Trogarzo

EMA will consider the application for registration of the drug for the treatment of HIV infection Trogarzo

On Tuesday, August 28, the Canadian pharmaceutical company Theratechnologies announced the filing of documents for the registration of the innovative drug for the treatment of HIV-1 with multiple drug resistance (MDR HIV-1) Trogarzo (ibalizumab) to the European Medicines ...

28 august 2018

6139

UNICEF: every hour 30 adolescents become infected with HIV. 2/3 - girls

UNICEF: every hour 30 adolescents become infected with HIV. 2/3 - girls

According to the report of the United Nations Children's Fund (UNICEF), adolescents 15-19 years, especially girls, are most affected by the global HIV / AIDS epidemic. According to the fund, every hour HIV is infected with about 30 teenagers, 20 of whom are girls.

27 august 2018

6038

Europe is close to achieving the goal of "90-90-90". But not all

Europe is close to achieving the goal of "90-90-90". But not all

According to a study published in the journal AIDS (JAIDS), Europe is close to achieving the goal of UNAIDS 90-90-90. According to the latest data, 81% of people living with HIV are aware of their status, 84% of them are receiving the necessary treatment, 88% of whom have ...

20 august 2018

7028

Former UN Secretary-General Kofi Annan died

Former UN Secretary-General Kofi Annan died

Former UN Secretary-General, Nobel Peace Prize winner Kofi Annan died at the age of 80. As Secretary General, he conducted UN reform, devoted a lot of time to the fight against HIV and implemented the UN Global Compact. In 2001, he made a proposal to create the Global Fund ...

18 august 2018

6944

Drug resistance to ARVT: new recommendations for testing and monitoring

Drug resistance to ARVT: new recommendations for testing and monitoring

Last month, a scientific journal on clinical infectious diseases published new recommendations of the International Antiviral Community (IAS) on testing and monitoring drug resistance to antiretroviral drugs used in HIV treatment.

16 august 2018

6240

Trogarzo affects the restoration of immunity

Trogarzo affects the restoration of immunity

The results of the 3 phase clinical trials of ibalizumab confirmed that the agent not only reduces the level of replication of drug-resistant strains of HIV, but also has a beneficial effect on restoration of immunity. According to scientists at Yale University, the use ...

15 august 2018

6007

GSK was told about the results of studies of prospective two-component ART

GSK was told about the results of studies of prospective two-component ART

#ViiV Healthcare, a division of the British pharmaceutical company GlaxoSmithKline, spoke about the promising results of studies of innovative therapy against HIV of cabotegravir / rilpivirin, which will reduce the intake of necessary medications from a daily dose of three ...

13 august 2018

7467

In the United States approved a new type of female contraceptive

In the United States approved a new type of female contraceptive

The US Food and Drug Administration (FDA) last Friday, August 10, approved the use of the innovative female contraceptive Annovera (a combination of estrogen and segesterone acetate). The contraceptive is an intravaginal ring that can be used by women throughout the year. ...

1 2